Alzheimer's damage in mice reduced with compound that targets APOE gene

People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer’s disease. Now, researchers at Washington University School of Medicine in St. Louis have identified a compound that targets the APOE protein in the brains of mice and protects against damage induced by the Alzheimer’s protein amyloid beta. The findings indicate that APOE could potentially be a real target for treatment or prevention. …read more

Source: EurekAlert

(Visited 3 times, 1 visits today)

Popular Posts